Entry Point Capital, LLC Trans Medics Group, Inc. Transaction History
Entry Point Capital, LLC
- $171 Million
- Q3 2024
A detailed history of Entry Point Capital, LLC transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Entry Point Capital, LLC holds 2,145 shares of TMDX stock, worth $142,642. This represents 0.2% of its overall portfolio holdings.
Number of Shares
2,145
Previous 99
2066.67%
Holding current value
$142,642
Previous $14.9 Million
97.75%
% of portfolio
0.2%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding TMDX
# of Institutions
397Shares Held
31.7MCall Options Held
466KPut Options Held
286K-
Vanguard Group Inc Valley Forge, PA3.6MShares$239 Million0.01% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$176 Million0.01% of portfolio
-
Driehaus Capital Management LLC Chicago, IL1.44MShares$95.9 Million2.22% of portfolio
-
State Street Corp Boston, MA1.27MShares$84.7 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA1.09MShares$72.8 Million0.03% of portfolio
About TransMedics Group, Inc.
- Ticker TMDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 31,831,400
- Market Cap $2.12B
- Description
- TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...